Corroborating this idea, the inhibition of the IKKβ–nuclear factor-κB (NF-κB) pathway via pharmacological and genetic means ameliorated insulin sensitivity in mice [26] and improved glycemic control in individuals with diabetes [33]. The gene discussed is INS; the disease is diabetes mellitus.